tiprankstipranks
Advertisement
Advertisement

WAT Stock Latest News

Waters price target lowered to $330 from $370 at UBS
The FlyWaters price target lowered to $330 from $370 at UBS
2d ago
WAT
Waters announces FDA clearance of Onclarity HPV Self-Collection Kit
PremiumThe Fly
Waters announces FDA clearance of Onclarity HPV Self-Collection Kit
7d ago
WAT
Waters upgraded to Outperform from In Line at Evercore ISI
PremiumThe Fly
Waters upgraded to Outperform from In Line at Evercore ISI
9d ago
WAT
Waters reinstated with a Buy at Goldman Sachs
PremiumThe Fly
Waters reinstated with a Buy at Goldman Sachs
14d ago
WAT
Waters price target lowered to $330 from $370 at Deutsche Bank
PremiumThe Fly
Waters price target lowered to $330 from $370 at Deutsche Bank
21d ago
WAT
Waters Subsidiary Completes $3.5 Billion Senior Notes Offering
PremiumCompany AnnouncementsWaters Subsidiary Completes $3.5 Billion Senior Notes Offering
23d ago
8K
WAT
Waters director buys $144.7K in common stock
Premium
The Fly
Waters director buys $144.7K in common stock
28d ago
WAT
Waters Details Financial Impact of Recent SpinCo Acquisition
Premium
Company Announcements
Waters Details Financial Impact of Recent SpinCo Acquisition
1M ago
8K
WAT
Waters price target lowered to $350 from $423 at Morgan Stanley
PremiumThe Fly
Waters price target lowered to $350 from $423 at Morgan Stanley
2M ago
WAT
Waters Corporation: Hold Rating Maintained as BD Acquisitions Temper Medium‑Term Growth and Drive Target Cut to $350
PremiumRatings
Waters Corporation: Hold Rating Maintained as BD Acquisitions Temper Medium‑Term Growth and Drive Target Cut to $350
2M ago
WAT
Buy Rating Reaffirmed on Temporary Headwinds and Credible Turnaround Path Post-BD Acquisition
PremiumRatings
Buy Rating Reaffirmed on Temporary Headwinds and Credible Turnaround Path Post-BD Acquisition
2M ago
WAT
Waters price target lowered to $370 from $395 at UBS
PremiumThe Fly
Waters price target lowered to $370 from $395 at UBS
2M ago
WAT
Waters price target lowered to $363 from $398 at Baird
PremiumThe FlyWaters price target lowered to $363 from $398 at Baird
2M ago
WAT
Waters price target lowered to $373 from $400 at TD Cowen
Premium
The Fly
Waters price target lowered to $373 from $400 at TD Cowen
2M ago
WAT
Waters resumed with an In Line at Evercore ISI
Premium
The Fly
Waters resumed with an In Line at Evercore ISI
2M ago
BDX
WAT
Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
PremiumRatings
Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
2M ago
WAT
Waters price target lowered to $350 from $410 at BofA
PremiumThe Fly
Waters price target lowered to $350 from $410 at BofA
2M ago
WAT
Waters reinstated with an Overweight at Barclays
PremiumThe Fly
Waters reinstated with an Overweight at Barclays
2M ago
WAT
Waters resumed with a Buy at Citi
PremiumThe Fly
Waters resumed with a Buy at Citi
2M ago
WAT
Waters Corp Earnings Call: Growth, Risks and Synergies
PremiumCompany AnnouncementsWaters Corp Earnings Call: Growth, Risks and Synergies
2M ago
WAT
Waters Closes Reverse Morris Trust, Forms Expanded Life Sciences Leader
Premium
Company Announcements
Waters Closes Reverse Morris Trust, Forms Expanded Life Sciences Leader
2M ago
8K
WAT
Waters sees Q1 non-GAAP EPS $2.25-$2.35, consensus $2.51
Premium
The Fly
Waters sees Q1 non-GAAP EPS $2.25-$2.35, consensus $2.51
2M ago
WAT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >